| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5701311 | European Journal of Surgical Oncology (EJSO) | 2017 | 24 Pages | 
Abstract
												In ESCC patients who achieve MaHR after nCRT, the presence of microscopical residual disease and the thoroughness of histopathological examination are associated with survival.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Oncology
												
											Authors
												Y.-K. Chao, W.-Y. Chuang, H.-K. Chang, C.-K. Tseng, C.-J. Yeh, Y.-H. Liu, 
											